DWTX
Dogwood Therapeutics, Inc. (DWTX) is rated C (2.3/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B+); its weakest is Profitability (D+). The rating has held at C for 5 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-11 | B+ (3.8) | D+ (1.8) | D+ (1.5) | D+ (1.7) | C+ (2.6) | C (2.3) |
| 2026-11-04 | B+ (3.8) | C- (1.9) | D+ (1.5) | C- (1.9) | C+ (2.7) | C (2.3) |
| 2026-10-28 | B+ (3.8) | C- (1.9) | D+ (1.6) | C- (2.0) | C+ (2.7) | C (2.4) |
| 2026-10-21 | B+ (3.8) | D+ (1.8) | D+ (1.6) | C (2.2) | C+ (2.6) | C (2.4) |
| 2026-10-14 | B+ (3.7) | D+ (1.8) | D+ (1.6) | C (2.5) | C+ (2.6) | C (2.4) |